Post by
Quentin30 on Nov 14, 2022 7:00pm
Timing of Phase III for Panc
Just for clarification. End of Phase II meeting will require a Type C meeting request, this will take 90 days. The end of Phase II meeting will inform what must be included in the Phase III design.
ONCY will need time to author their IND, which FDA could assess within 30 days.
So realistically, the earliest a Phase III or even Phase II/III for Panc could possibly start will be mid Q2 2023.
That may be of value to some here, and could certainly be an inflection point.
Comment by
Hcallahan44 on Nov 15, 2022 4:04pm
Thanks Quentin...but what of KSW's point....the BPs are will run the Phase III after an acquisition...i have a biotech savvy friend who says that wont happen...the BPs will hold off and let us do the work....but if KSW is right....this wont be an issue. The market seems to be saying you are correct....if an acquisition was anywhere near....the stock would be jumping on heavy volume....
Comment by
westcoast1000 on Nov 15, 2022 7:48pm
Quentin, I see it entirely differently. Matt saying he hopes to have news of a partnership next year tells me he IS already in discussions with BP for obvious reasons. The reasons are the results. But then we all can make our own interpretations of what he said. We will know in the near to distant future, as they say.
Comment by
Buckhenry on Nov 15, 2022 7:51pm
this is my whole point. not one of us are in the know here yet some here think they are omnipotent.